Covadonga Pañeda - Concepedia

Author

Covadonga Pañeda

Instituto de Investigaciones Biomédicas Sols-Morreale ORCID

Also Known As

C PAñEDA, C Pañeda, C. Pañeda, Covadonga Paneda, Covadonga Pañeda, Covadonga Pañeda, Pañeda, Covadonga

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigaciones Biomédicas Sols-Morreale Universidad Autónoma de Madrid Hospital Infantil Universitario Niño Jesús University of the Basque Country Menéndez Pelayo International University

About

Covadonga Pañeda is an author at Instituto de Investigaciones Biomédicas Sols-Morreale specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	341
2	Health Sciences	2	2	172
3	Biochemistry	2	2	74
4	Natural Sciences	1	1	60
5	Social Sciences	1	1	49

Covadonga Pañeda

Publications

Citations

H-Index

Page 1

	Year	Citations
Growth Hormone (GH) and GH-Releasing Peptide-6 Increase Brain Insulin-Like Growth Factor-I Expression and Activate Intracellular Signaling Pathways Involved in Neuroprotection Laura M. Frago, Covadonga Pañeda, Suzanne L. Dickson, Endocrinology Human GrowthBrain Igf SystemNeuroendocrine MechanismHypothalamic PeptideNeurology	2002	127
In Vitro and In Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma Tamara Martı́nez, Marı́a Victoria González, Ingo Roehl, Molecular Therapy	2013	111
Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6‐methyl‐phenyl‐tetrahydropyridine toxicity Bruno Conti, Shuei Sugama, Jacinta Lucero, Journal of Neurochemistry	2005	105
Neuropeptide S Reinstates Cocaine-Seeking Behavior and Increases Locomotor Activity through Corticotropin-Releasing Factor Receptor 1 in Mice Covadonga Pañeda, Salvador Huitrón‐Reséndiz, Laura M. Frago, Journal of Neuroscience	2009	105
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease J.M. Benítez-del-Castillo, Javier Moreno‐Montañés, Ignacio Jiménez-Alfaro, Investigative Ophthalmology & Visual Science	2016	97
Phase I Clinical Trial of SYL040012, a Small Interfering RNA Targeting β-Adrenergic Receptor 2, for Lowering Intraocular Pressure Javier Moreno‐Montañés, Belén Sádaba, Verónica Ruz, Molecular Therapy	2013	75
Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor–induced lethal hepatitis Anna Colell, Albert Morales, Covadonga Pañeda, Journal of Clinical Investigation	2004	67
Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor–induced lethal hepatitis Anna Colell, Albert Morales, Covadonga Pañeda, Journal of Clinical Investigation ImmunologyPathologyCell DeathOxidative StressInflammation	2004	60
Activation of the intrinsic cell death pathway, increased apoptosis and modulation of astrocytes in the cerebellum of diabetic rats Alfonso M. Lechuga‐Sancho, Ana I. Arroba, Laura M. Frago, Neurobiology of Disease NeurophysiologyDiabetesAutophagyApoptosisCell Death	2006	49
Differential expression and localization of transient receptor potential vanilloid 1 in rabbit and human eyes. Carmen Martínez‐García, Tamara Martı́nez, Covadonga Pañeda, PubMed	2013	48

Page 1